USPTO Patent Application: Radiation Dose Optimization for Particle Emitter
Summary
The USPTO has published a new patent application detailing a method for concurrent optimization of radiation doses for particle emitter devices across multiple treatment phases. The application, filed by Roni Hytonen, Perttu Niemelä, and Lauri Halko, aims to improve treatment efficacy by dynamically adjusting radiation doses based on phase-specific objectives.
What changed
This document is a publication of a United States Patent Application (US20260083983A1) filed on September 26, 2024. The application describes a technical solution for concurrently optimizing radiation doses for particle emitter devices across different operational phases. Key aspects include determining first and second radiation doses for distinct phases, generating phase-specific metrics, calculating a combined dose, and modifying doses to reduce this combined metric before emission.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it represents a novel technological development in the field of radiation therapy and medical devices. Companies involved in the development or manufacturing of particle emitter devices, radiation therapy equipment, or related software may find this patent relevant for understanding potential future technological advancements and competitive landscapes.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CONCURRENT OPTIMIZATION OF PARTICLE EMITTER SYSTEM FOR MULTI-PHASED TREATMENT
Application US20260083983A1 Kind: A1 Mar 26, 2026
Inventors
Roni Hytonen, Perttu Niemelä, Lauri Halko
Abstract
Aspects of this technical solution can determine a first dose of radiation concurrently with a second dose of radiation, the first dose associated with a first phase of operation of a particle emitter device, and the second dose associated with a second phase of operation of a particle emitter device, generate a first phase metric concurrently with a second phase metric, the first phase metric for a first objective on the first dose during the first phase, and the second phase metric for a second objective on the second dose during the second phase, determine, based on the first dose and the second dose, a combined dose over the first phase and the second phase, modify, at least one of the first dose or the second dose to reduce the combined metric, and cause the particle emitter device to emit the first dose and the second dose.
CPC Classifications
A61N 5/1031 G16H 20/40 A61N 2005/1087
Filing Date
2024-09-26
Application No.
18898510
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Health Informatics (G16H)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Health Informatics (G16H) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.